We are live on ! Find out more
AUTL

Autolus Therapeutics
AUTL

35 hedge funds and large institutions have $569M invested in Autolus Therapeutics in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.74% more ownership

Funds ownership: 42.31% → 45.05% (+2.7%)

2% more capital invested

Capital invested by funds: $558M → $569M (+$11.3M)

8% less funds holding

Funds holding: 38 → 35 (-3)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

43% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 14

Holders
35
Holders Change
-3
Holders Change %
-7.89%
% of All Funds
0.76%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
5
Increased
8
Reduced
14
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$24.2M
2
Millennium Management
Millennium Management
New York
+$12.5M
3
WIM
Woodford Investment Management
United Kingdom
+$3.3M
4
Marshall Wace
Marshall Wace
United Kingdom
+$3.2M
5
TAM
TFG Asset Management
Cayman Islands
+$1.47M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$7.74M
2
Jennison Associates
Jennison Associates
New York
-$3.51M
3
OAM
Oxford Asset Management
United Kingdom
-$1.6M
4
N
Nuveen
North Carolina
-$928K
5
AG
Artal Group
Luxembourg
-$711K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
26
Tower Research Capital (TRC)
New York
$96K +$86.5K +3,041 New
Barclays
27
Barclays
United Kingdom
$47K -$55.8K -1,961 -57%
PCM
28
Prelude Capital Management
New York
$12K -$199 -7 -2%
Wells Fargo
29
Wells Fargo
California
$9K -$7.11K -250 -45%
Citigroup
30
Citigroup
New York
$8K +$7.54K +265 New
Daiwa Securities Group
31
Daiwa Securities Group
Japan
$4K -$2.42K -85 -43%
Deutsche Bank
32
Deutsche Bank
Germany
$2K +$2.62K +92 New
Bank of America
33
Bank of America
North Carolina
$1K -$25.6K -901 -95%
Legal & General Group
34
Legal & General Group
United Kingdom
$1K – – –
Morgan Stanley
35
Morgan Stanley
New York
$1K +$768 +27 New
DM
36
Deerfield Management
New York
– -$7.74M -235,576 Closed
Jennison Associates
37
Jennison Associates
New York
– -$3.51M -106,971 Closed
OAM
38
Oxford Asset Management
United Kingdom
– -$1.6M -48,672 Closed
N
39
Nuveen
North Carolina
– -$928K -28,267 Closed
BFM
40
Boothbay Fund Management
New York
– -$263K -8,000 Closed
ProShare Advisors
41
ProShare Advisors
Maryland
– -$201K -6,121 Closed
UBS Group
42
UBS Group
Switzerland
– -$29K -884 Closed
IA
43
IFP Advisors
Florida
– -$2K -50 Closed
1
2

AUTL Hedge Fund Activity: Q1 2019 in Review

35 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Autolus Therapeutics (AUTL) for Q1 2019, worth a combined $569M — up 2% from $558M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of AUTL and 5 opened new positions — a net loss of 3 holders — while 14 trimmed existing stakes and 8 added.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $24.2M. The largest seller was Deerfield Management, exiting entirely with an estimated $7.74M sold.

  • 35 institutional investors held Autolus Therapeutics (AUTL) as of Q1 2019, down from 38 in Q4 2018.
  • Funds reported $569M of Autolus Therapeutics stock for Q1 2019, up 2% quarter-over-quarter.
  • 5 funds opened new Autolus Therapeutics positions in Q1 2019 and 8 closed out, a net change of -3 holders.
  • The largest Autolus Therapeutics buyer in Q1 2019 was Cormorant Asset Management, an estimated $24.2M added.
  • The largest Autolus Therapeutics seller in Q1 2019 was Deerfield Management, an estimated $7.74M sold.

Based on aggregated 13F filings for Q1 2019.